One of our greatest assets is the people working at RegenTX. Our Management Team consists of renowned experts in the specific fields of human cell and tissue processing. What they all have in common is the commitment to improving the health of millions of patients suffering from severe or chronic medical conditions. Together they are working intensively to accelerate innovation in human tissue solutions to address persistent medical needs.
Monica ensures quality and compliance with FDA regulations, AATB standards, and industry practices while establishing a balance between risk-based thinking and lean practices.
She has 8+ years of experience in various FDA regulated industries, including birth tissue, cord blood, cadaveric tissue, medical devices, and pharmaceuticals.
Monica holds a Bachelor of Science degree in Microbiology with a minor in Chemistry from Texas State University. She also has a Master of Science in Healthcare Administration from Texas Tech University Health Science Center.
Being responsible for RegenTX’s operations, Pablo leads the execution of the company’s vision and drives initiatives to increase the financial footprint of the organization.
Pablo brings over twenty years of experience in operations, tissue banking, and executing business strategy. His previous roles include Director of Operations at CorneaGen and Technical Program Manager at Tissue Banks International and Director of Operations at Keralink International.
Pablo holds an MBA degree in Business Administration and Project Management from Louisiana State University and a BS in Biology from the University of Texas. He is also a certified Lean Practitioner and Six Sigma Black Belt.
We would like to welcome Milos Marinkovic, PhD, to the organization as our new Sr. Director of Product Research and Product Development. Milos comes to us with a background in biochemistry from the University of Texas at Austin and a Ph.D. in biomedical engineering from the University of Texas Health Science Center at San Antonio. In December 2019, he joined the faculty at UT Health.
In 2021, awarded a Research Health Scientist cross-appointment at the South Texas VA, receiving a Biomedical Laboratory Research and Development Career Development Award (CDA-2) from the US Department of Veterans Affairs while serving as an Assistant Professor. In this new position Milos will be overseeing all aspects of Product Development, Product Testing and Product Research. Milos will report to Oliver Burckhardt, President RegenTX Partners LLC and RegenTX Labs LLC.
As she leads our technology initiatives, Laura’s focus is on product innovation and process efficiency. She also oversees the RegenTX Partners Laboratories.
Before joining the company, she gained 7 years of in-depth experience in tissue banking with intimate knowledge of human cells and tissue-based products (HCT/Ps) in both, scientific and regulatory realms.
Laura holds a Bachelor of Science in Biology and is a Certified Tissue Bank Specialist (CTBS).
I am pleased to announce the promotion of Joanna Marquez to Director of Product Development.
Joanna joined us in January 2023 and very quickly became an important asset to the organization.
Joanna joined us with a background in biomedical engineering and a master’s in biotechnology
commercialization from the University of Texas at San Antonio. She has served as a Project Engineer,
Quality Assurance Engineer, and Biomedical Engineer in pervious roles prior to joining RegenTX Partners.
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds